Leukogene Therapeutics, Inc.

MOUNT PLEASANT, SC 29466

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $448K
First Award Date 09/18/13
Most Recent Award Date 09/22/16

Key Personnel

Last Name Name Awards Contact
Marcoux Frank W. Marcoux 2

2 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-15-270
Budget: 09/22/16 - 08/31/17

Project Summary/Abstract Multiple Myeloma (MM) is the second most common form of blood cancer and remains an incurable and deadly disease. Proteasome inhibitor (PI) therapy is a cornerstone in the treatment of MM, but resistance to this class of agent is an emerging challenge in the clinic. New therapeutic approaches that specifically target res...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-12-089
Budget: 09/18/13 - 08/31/14

DESCRIPTION (provided by applicant): Multiple Myeloma (MM) is a deadly plasma cell malignancy. Treatment advances have improved clinical outcomes over the past decade, but the disease remains incurable, thus creating a need for new and innovative treatment options. The MM drug pipeline includes several proteasome inhibitors and immunomodulatory ...